U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
142441142441Clomiphene in Males With Prolactinomas and Persistent HypogonadismCompletedNo Results AvailableHypogonadotropic Hypogonadism|ProlactinomaDrug: Clomiphene citratehttps://ClinicalTrials.gov/show/NCT00697814
142442142442Study of MAP0010 in Asthmatic Children and AdolescentsCompletedHas ResultsAsthmaDrug: MAP0010 low dose|Drug: MAP0010 high dose|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00697801
142443142443Dexmedetomidine Cardiovascular Safety in Pediatric Burn PatientsCompletedNo Results AvailableBurns|SedationDrug: Dexmedetomidinehttps://ClinicalTrials.gov/show/NCT00697788
142444142444Safety and Immunogenicity of GSK Bio's Candidate HBV-MPL Vaccines Compared to Engerixâ„¢-B, in Healthy AdolescentsCompletedNo Results AvailableHepatitis BBiological: HBV-MPL vaccine Formulation A|Biological: HBV-MPL vaccine Formulation B|Biological: Engerixâ„¢-Bhttps://ClinicalTrials.gov/show/NCT00697775
142445142445Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset SeizuresTerminatedNo Results AvailableSeizuresDrug: RWJ-333369|Drug: RWJ-333369|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00697762
142446142446Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Healthy Volunteers Positive for the HLA-DQ2 GenotypeCompletedNo Results AvailableHepatitis BBiological: HBV-MPL vaccine 208129|Biological: Engerixâ„¢-Bhttps://ClinicalTrials.gov/show/NCT00697749
142447142447Cardiac Repercussion of Systemic SclerodermiasActive, not recruitingNo Results AvailableSystemic SclerodermaProcedure: Echocardiography with myocardial tissular Doppler modehttps://ClinicalTrials.gov/show/NCT00697736
142448142448Arterial Versus Venous Graft Recruitment by Intra-Aortic Balloon PumpCompletedNo Results AvailableCoronary Artery DiseaseProcedure: Transit-time flowmetryhttps://ClinicalTrials.gov/show/NCT00697723
142449142449A Phase Ib/IIa, Double-Blind, Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of S-777469 in Subjects With Atopic DermatitisCompletedNo Results AvailableAtopic DermatitisDrug: 50 mg S-777469|Drug: 200 mg S-777469|Drug: 800 mg S-777469|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00697710
142450142450A Study of 2 Doses of MAP0010 in Asthmatic ChildrenTerminatedHas ResultsAsthmaDrug: 0.135mg MAP0010|Drug: 0.25mg MAP0010https://ClinicalTrials.gov/show/NCT00697697
142451142451Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell TransplantActive, not recruitingNo Results AvailableAcute Myeloid Leukemia|Myelodysplastic Syndrome|Acute Lymphocytic Leukemia|Relapsed/Refractory Chronic Lymphocytic Leukemia|Relapsed/Refractory Non Hodgkin's Lymphoma|Hodgkins Disease|Relapsed Refractory Multiple MyelomaDrug: Antithymocyte Globulin|Drug: Clofarabine|Drug: Clofarabine|Drug: Clofarabinehttps://ClinicalTrials.gov/show/NCT00697684
142452142452Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic MalignanciesCompletedNo Results AvailableAcute Lymphoblastic Leukemia|Chronic Myelogenous Leukemia|Juvenile Myelomonocytic Leukemia|Myelodysplastic Syndrome|Non-Hodgkin's LymphomaOther: NK Cell Infusion|Biological: Immunotherapy|Device: Miltenyi Biotec CliniMACS device|Drug: Interleukin-2 (IL-2)|Drug: Clofarabine|Drug: Cyclophosphamide|Drug: Etoposidehttps://ClinicalTrials.gov/show/NCT00697671
142453142453INVISION - An Observational Study to Explore Effectiveness, Tolerability and Safety of Paliperidone ER in Patients With SchizophreniaCompletedNo Results AvailableSchizophreniaDrug: Paliperidone ERhttps://ClinicalTrials.gov/show/NCT00697658
142454142454Use of Deep Transcranial Magnetic Stimulation After StrokeNot yet recruitingNo Results AvailableStrokeDevice: Deep TMS (Transcranial magnetic stimulation)|Device: Brainsway Deep TMShttps://ClinicalTrials.gov/show/NCT00697645
142455142455Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced MalignanciesRecruitingNo Results AvailableAdvanced CancerDrug: MGCD265https://ClinicalTrials.gov/show/NCT00697632
142456142456To Evaluate the Efficacy of ZOMETA® in Treatment of Bone Metastases in Patients With Stage IV Nasopharyngeal CancerCompletedHas ResultsNasopharyngeal CancerDrug: Zometa (zoledronic acid)https://ClinicalTrials.gov/show/NCT00697619
142457142457Seprafilm® for Prevention of Adhesions at Repeat CesareanTerminatedNo Results AvailableAdhesion Formation After Primary Cesarean DeliveryDevice: Seprafilm®|Other: Controlhttps://ClinicalTrials.gov/show/NCT00697606
142458142458ChangE From Any Systemic psoriasiS therapY to RaptivaTerminatedHas ResultsChronic Plaque PsoriasisDrug: Efalizumab - anti CD11a recombinant human monoclonal antibody (mAb)https://ClinicalTrials.gov/show/NCT00697593
142459142459Strength and Nutrition Outcomes for Latino AdolescentsCompletedNo Results AvailableObesity|Type 2 Diabetes|Cardiovascular Risk|CancerBehavioral: Control|Behavioral: Nutrition|Behavioral: Strength Training & Nutrition|Behavioral: Circuit Training & Nutritionhttps://ClinicalTrials.gov/show/NCT00697580
142460142460Evaluation of Immunogenicity, Reactogenicity and Safety of Herpes Simplex (gD) Candidate Vaccine With/Without AdjuvantCompletedNo Results AvailableProphylaxis Herpes SimplexBiological: Herpes simplex candidate vaccine GSK208141 - non-MPL-containing adjuvant|Biological: Herpes simplex candidate vaccine GSK208141- MPL-containing adjuvanthttps://ClinicalTrials.gov/show/NCT00697567
142461142461Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Pre-Liver Transplant Patients 18 Years of AgeCompletedNo Results AvailableHepatitis BBiological: HBV-MPL vaccine 208129|Biological: Engerixâ„¢-Bhttps://ClinicalTrials.gov/show/NCT00697554
142462142462Systemic Bioavailability Study Of Col-118 Administered Topically as a 0.18 % Facial Gel And Brimonidine Ophthalmic Solution 0.2%CompletedHas ResultsErythematous RosaceaDrug: 0.18% COL-118 facial gel (1.8 mg brimonidine)|Drug: 0.2% brimonidine ophthalmic solution (0.1 mg brimonidine tartrate/drop)|Drug: Advanced Eye Relief|Drug: COL-118 facial gel vehiclehttps://ClinicalTrials.gov/show/NCT00697541
142463142463Color Doppler Imaging of Orbital Venous Flow in Grave's OrbitopathyCompletedNo Results AvailableGraves' Disease|Graves' Ophthalmopathyhttps://ClinicalTrials.gov/show/NCT00697528
142464142464Safety and Efficacy Workplace Environment Study of Lisdexamfetamine Dimesylate (LDX) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)CompletedHas ResultsADHDDrug: LDX|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00697515
142465142465Study of Capecitabine In Patients With Solid TumorsCompletedNo Results AvailableSolid TumorsDrug: Capecitabinehttps://ClinicalTrials.gov/show/NCT00697502
142466142466Treatment of Urinary Stress Incontinence During or Following Correction of Pelvic Organ ProlapseWithdrawnNo Results AvailablePelvic Organ ProlapseProcedure: correction of POP plus preventive continence procedure|Procedure: POP surgery followed by eventual incontinence procedurehttps://ClinicalTrials.gov/show/NCT00697489
142467142467Study of Oral Vorinostat in Combination With Topotecan in Patients With Chemosensitive Recurrent SCLCTerminatedNo Results AvailableSmall Cell Lung CancerDrug: topotecan, vorinostathttps://ClinicalTrials.gov/show/NCT00697476
142468142468Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal WomenActive, not recruitingNo Results AvailableMenopause|Fracture|OsteoporosisDrug: Teriparatide (PTH 1-34)https://ClinicalTrials.gov/show/NCT00697463
142469142469Observational Study on the Weight Effect of Insulin Detemir (Levemir®) in Type 2 DiabeticsCompletedNo Results AvailableDiabetes|Diabetes Mellitus, Type 2Drug: insulin detemirhttps://ClinicalTrials.gov/show/NCT00697450
142470142470Effect of Ketoconazole Inhibition of CYP3A on Urinary Excretion of DocetaxelCompletedNo Results AvailableSolid TumorsDrug: Docetaxel|Drug: Ketoconazolehttps://ClinicalTrials.gov/show/NCT00697437

* Görseller ve İçerik tekif hakkına sahip olabilir